Jean Soderquist, PH.D. Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2880 W 4700 S, Suite A, West Valley City, UT 84118 Phone: 801-964-2465 Fax: 801-964-9075 |
Joriann Lynn Mcgrath Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5698 W Glen Eagle Dr, West Valley City, UT 84128 Phone: 801-969-4181 |
Mr. Adam Adair Green, MFTI Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 5698 W Glen Eagle Dr, West Valley City, UT 84128 Phone: 801-969-4181 |
Sonnet Hintze, MFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 3280 W 3500 S Ste E, West Valley City, UT 84119 Phone: 801-979-1351 Fax: 801-905-1161 |
Sandra Kushnir, M.S., MFTI Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2943 W Parkway Blvd, West Valley City, UT 84119 Phone: 323-332-9905 |
News Archive
A new study by researchers at the University of Connecticut Health Center, USA, reports the crucial nature of the pathogen pattern recognition receptor (PRRs), especially the two RLRs, retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5), in triggering host cell immune responses within the cell. The RLRs are viral RNA sensors.
New blood pressure targets are low enough to be unachievable for most patients, say experts from Aberdeen University in this week's BMJ.
Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.
Women who were born with a low birthweight are at increased risk of pregnancy complications, according to a new Obesity study. The findings suggest that women who were born small may have been affected by unfavorable intrauterine conditions, and the physiological demands of pregnancy may act as a "second hit" leading to pregnancy complications.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
› Verified 1 days ago